Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Brain - A Journal of Neurology Year : 2017

Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology

Abstract

No abstract available

Domains

Human health and pathology
Embargoed file
Embargoed file
Ne sera jamais visible

DAVID KLATZMANN  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-01617417

Submitted on : Tuesday, November 15, 2022-3:37:03 PM

Last modification on : Tuesday, April 11, 2023-5:37:20 PM

Long-term archiving on: Thursday, February 16, 2023-8:11:49 PM

Embargoed file
Please log in to request access to the document

Dates and versions

inserm-01617417 , version 1 (15-11-2022)

Identifiers

Cite

Sandro Alves, Guillaume Churlaud, David Klatzmann, Nathalie Cartier. Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology. Brain - A Journal of Neurology , 2017, 140 (7), pp.e40 - e40. ⟨10.1093/brain/awx109⟩. ⟨inserm-01617417⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM CEA UPMC CNRS CEA-UPSAY UNIV-PARIS-SACLAY SORBONNE-UNIVERSITE SU-MEDECINE FRM
44 View
2 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More